Impetis Biosciences Limited

Impetis Biosciences Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U74999MH2017PLC295474 Incorporated 29 May 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.61 Cr
▼ 71.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹4.9 Cr
Registered with MCA
Paid-up capital
₹3.73 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
2
Latest available

About Impetis Biosciences Limited

Data last updated: 07 March 2026

Impetis Biosciences Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Tata Sons Private Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 29 May 2017, the company has been in operation for over 9 years.

Registered with ROC Mumbai under CIN U74999MH2017PLC295474.

Capital: an authorised share capital of ₹4.9 Cr and a paid-up capital of ₹3.73 Cr. It is led by directors including Abhishek Jain and Kanwar Rameshwar Singh Jamwal.

Last AGM: 24 June 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.61 Cr, a decline of 71% compared to the previous year.

The company has a workforce of approximately 2 employees as per the latest available data. It operates as a subsidiary of Tata Sons Private Limited.

The company is associated with 1 brand - Impetis.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website impetisbiosciences.com.

Company Details of Impetis Biosciences Limited
CIN U74999MH2017PLC295474
Registration Number 295474
Incorporation Date 29 May 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Tata Sons Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    6Th Floor Wing E Times Square, Marol Andheri – Kurla Road Gamdevi Andheri – East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Pharma Contract R&D
Company report
Impetis Biosciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Impetis Biosciences Limited report

Financials, compliance, directors, charges, ownership and filings for Impetis Biosciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Impetis Biosciences Limited

Impetis Biosciences Limited operates one associated brand: Impetis. These brands represent Impetis Biosciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Drug discovery and licensing for auto-immune, inflammatory, and oncology treatments via partnerships. impetisbiosciences.com

Competitors & Alternatives of Impetis Biosciences Limited

Brands and companies operating in the same space as Impetis Biosciences Limited include Moderna, argenx, BeiGene and 6 more.

Competitor Description Location Founded
Moderna Moderna mRNA-based therapeutics for diseases including cancer and infections are developed. Cambridge, United States, United States 2010
argenx argenx Antibody-based drugs are developed for autoimmune diseases and cancer treatment. Ghent, Belgium, Belgium 2008
BeiGene BeiGene Targeted and immune-oncology drugs for cancer treatment are developed. Cambridge, United States, United States 2010
Forge Biologics Forge Biologics Gene therapies for rare diseases are developed to treat patients. Columbus, United States, United States 2020
Annexon Annexon Developer of antibodies to treat complement-mediated neurodegenerative diseases San Francisco, United States, United States 2011
Horizon Therapeutics Horizon Therapeutics Developer of drugs for treating rare and autoimmune diseases Dublin, Ireland, Ireland 2008
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Incyte Incyte Small molecules are developed for cancer and skin disease treatments. Wilmington, United States, United States 1991
ALX Oncology ALX Oncology ALX Oncology is focused on advancing cancer treatment therapies. Burlingame, United States, United States 2015

Business Activity of Impetis Biosciences Limited

Impetis Biosciences Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M9 Other professional, scientific and technical activities Locked
Premium access

Business activity turnover details for Impetis Biosciences Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Impetis Biosciences Limited

Impetis Biosciences Limited is audited by M. A. PARIKH & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M. A. PARIKH & CO. Locked Locked Locked
Premium access

Complete auditor history for Impetis Biosciences Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Impetis Biosciences Limited

Impetis Biosciences Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Abhishek Jain Director 04 Mar 2024 2 Years 4 Months Current
Kanwar Rameshwar Singh Jamwal Director 29 May 2017 9 Years 1 Months Current
Tarun Dayal Bhojwani Director 16 Jan 2025 1 Years 6 Months Current

Financials of Impetis Biosciences Limited FY 2025 filings available

Impetis Biosciences Limited reported revenue of ₹1.61 Cr (down 71.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.61 Cr ▼ 71.00%
Premium access

Ten-year financial statements for Impetis Biosciences Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Impetis Biosciences Limited

Premium access

Shareholding and ownership data for Impetis Biosciences Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Impetis Biosciences Limited

Impetis Biosciences Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Impetis Biosciences Limited

Impetis Biosciences Limited has a workforce of 2 employees as of Apr 10, 2024.

Employee count
2
Active EPFO establishments
1
Premium access

Employee and EPFO history for Impetis Biosciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Impetis Biosciences Limited

Premium access

GST registrations and filing compliance for Impetis Biosciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Impetis Biosciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Impetis Biosciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Impetis Biosciences Limited

Premium access

MSME payment history for Impetis Biosciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Impetis Biosciences Limited

Premium access

Corporate group structure for Impetis Biosciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Impetis Biosciences Limited

Premium access

MCA filings and documents for Impetis Biosciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Impetis Biosciences Limited

Activity
24 Jun 2025
Impetis Biosciences Limited last Annual general meeting of members was held on 24 Jun 2025 as per latest MCA records.
Activity
31 Mar 2025
Impetis Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
16 Jan 2025
Tarun Dayal Bhojwani was appointed as a Director on 16 Jan 2025 & has been associated with this company since 1 year 6 months.
Directors
04 Mar 2024
Abhishek Jain was appointed as a Director on 04 Mar 2024 & has been associated with this company since 2 years 4 months.
Directors
29 May 2017
Kanwar Rameshwar Singh Jamwal was appointed as a Director on 29 May 2017 & has been associated with this company since 9 years 1 month.
Activity
29 May 2017
Impetis Biosciences Limited was registered on 29 May 2017 with Roc Mumbai I & aged 9 years 1 month as per MCA records.

Frequently Asked Questions about Impetis Biosciences Limited

Impetis Biosciences Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999MH2017PLC295474. The company has 2 employees.

Impetis Biosciences Limited reported revenue of ₹1.61 Cr for FY 2025 (down 71.00% YoY).

The current directors of Impetis Biosciences Limited are:

The primary industry of Impetis Biosciences Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Impetis Biosciences Limited can be reached at the registered office: 6Th Floor Wing E Times Square, Marol Andheri – Kurla Road Gamdevi Andheri – East, Mumbai, Maharashtra, India – 400059, or through the website impetisbiosciences.com.

The authorised capital is ₹4.9 Cr, and the paid-up capital is ₹3.73 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available